Treatment | Children with Cancer UK

Filter by Cancer Type

Modification of the Asparaginase-based drugs for ALL

Modification of the Asparaginase-based drugs for ALL

Dr Oleg Gerasimenko, Cardiff University

Identifying new leukaemia treatments by targeting cholesterol and fatty acid dependence

Harnessing SMAD7 induced transcriptional pathways for novel anti-leukaemia therapies

Dr Owen Williams, UCL Great Ormond Street Institute of Child Health

New neuroblastoma treatments could increase likelihood of irradiating all cancerous tissue in the body

Two radiopharmaceuticals for treatment of neuroblastoma

Professor Anthony Chalmers, University of Glasgow

Non-genotoxic combination treatments for paediatric acute leukaemias

Non-genotoxic combination treatments for paediatric acute leukaemias

Professor Olaf Heidenreich, Newcastle University

DIPG Research: developing new immunotherapy techniques to target currently incurable brain tumours

TCR-transduced T cells for immunotherapy of paediatric high grade glioma

Professor John Anderson, UCL Institute of Child Health and Great Ormond Street Hospital

Developing our understanding of how bilateral neuroblastoma develops

The developmental history of bilateral neuroblastoma

Sarah Farndon, UCL Institute of Child Health

1 … 4 5 6 7 8 … 18